ZR2 Bioenergy Limited has submitted a formal clarification to the BSE Limited in response to an exchange communication seeking details on the significant movement in the company's share price.
The company confirms that it has consistently complied with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key clarifications provided are:
- The company states there is no undisclosed pending material information, event, or announcement concerning its operations or performance that, in its opinion, has a bearing on the price or volume behavior of the scrip.
- The company attributes the recent significant share price movement to be purely market-driven and reliant on market conditions.
- The company reaffirms its commitment to compliance, stating it has always informed stock exchanges of all relevant information in a timely manner and will continue to disseminate any material information as required under applicable regulations.
The letter, signed by Managing Director Jimmy Olsson (DIN: 06891122), requests the exchange to take the clarification on record and disseminate it to investors and the general public.
The company's registered office is located at Survey No. 146, Plot No. 314, 307, 3rd Floor, Ashirwad Paras-1, S. G. Highway, Makarba, Ahmedabad, Gujarat, India, 380051, with CIN L32909GJ1939PLC002480.